Study of the susceptibility of human colorectal tumor explants to lak-cell lysis: Comparison of various cytotoxicity tests

The susceptibility of tumor cells from cultures of 8 human colorectal tumor explants to a standard LAK preparation originating from a single healthy donor was assessed in 5 various cytotoxic tests. Target cells were suspended or attached (in three different 51Cr‐release 4 hr tests), grown as a confl...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical laboratory analysis Vol. 7; no. 3; pp. 155 - 163
Main Authors Ochalek, Tomasz, Kleist, Sabine Von
Format Journal Article
LanguageEnglish
Published New York Wiley Subscription Services, Inc., A Wiley Company 1993
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The susceptibility of tumor cells from cultures of 8 human colorectal tumor explants to a standard LAK preparation originating from a single healthy donor was assessed in 5 various cytotoxic tests. Target cells were suspended or attached (in three different 51Cr‐release 4 hr tests), grown as a confluent monolayer (in a colorymetric 72 hr test) and grown as three‐dimensional spheroids (in a 51Cr‐release 24 hr assay). The susceptibility to lysis observed for one tumor in the 5 tests varied from 4 to 15 times and was a tumor attribute independent of the susceptibility to lymphocyte attack. There was no correlation of results between the 4 hr tests and a 72 hr test performed on monolayer, or the spheroid test taking into account the resistance of the three‐dimensional structure to lymphocyte invasion. Our study excludes the possibility of quantitative interpolation of assessments of tumor cell susceptibility to lymphocytes received from various tests. It also refers to simple reductionist tests which may be compared, however, after ranking the qualitative categories. © 1993 Wiley‐Liss, Inc.
Bibliography:istex:0285ED2D24248751BF0F40340D83FF62F14D926E
ark:/67375/WNG-KFS7K4DS-L
ArticleID:JCLA1860070305
ISSN:0887-8013
1098-2825
DOI:10.1002/jcla.1860070305